次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

組み換えたんぱく質の世界市場:製品別、用途別2026年予測

Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development, Academic Research), End User (Biotechnology Companies, CROs) - Global Forecast to 2026

出版元:MarketsandMarketsLinkIcon出版元について
発行年:2021年2月
定価 Single User License(1名様ライセンス)US$4,950(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文172ページになります。
商品コード:MAM2318

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
組み換えたんぱく質の世界市場規模は、2021年の推計10億ドルから、2026年には17億ドルへと漸増する見通しです。レポートは組み換えタンパク質の世界市場について2026年までの市場予測データ(金額US$)を掲載しています。また市場をさまざまな切り口で細分化し、そのセグメント市場ごとの市場予測を中心に構成されています。当レポートでの各種セグメント市場の区分および項目は、製品別市場(成長因子/ケモカイン、免疫応答タンパク質など)、用途別市場(創薬/開発各種、学術研究など)、エンドユーザー別市場(製薬会社/バイオ医薬品会社、バイオテクノロジー企業など)および主要国地域別市場、などとなっています。また競合状況、主要企業情報(26社)、COVID-19による組み換えタンパク質市場への影響、バリューチェーン分析などの分析情報も加味し、組み換えタンパク質市場の今後成長性および動向を詳細にレポートしています。

 

【レポート構成概要】
◆組み換えタンパク質の世界市場予測2019-2026年
・市場規模(US$)

◆製品別、市場-2026年
・成長因子/ケモカイン
・免疫応答タンパク質
・構造タンパク質
・膜タンパク質
・キナーゼタンパク質
・調節タンパク質
・組み換え代謝酵素
・接着分子/受容体
・その他組み換えタンパク質
※(市場規模US$) 

◆用途別、市場-2026年
創薬/開発
・生物製剤
・ワクチン
・細胞/遺伝子治療
学術研究
バイオ医薬品製造
バイオテクノロジー研究
その他用途
※(市場規模US$) 

◆エンドユーザー別、市場-2026年
・製薬会社/バイオ医薬品会社
・バイオテクノロジー企業
・学術研究機関
・医薬品開発受託研究機関(CRO)
・その他エンドユーザー
※(市場規模US$) 

◆主要国地域別市場-2026年
北米
・米国、カナダ
欧州
・英国、ドイツ、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照

◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会)
・COVID-19による組み換えタンパク質市場への影響
・バリューチェーン分析
・ファイブフォース分析
・市場シェア分析
・競合状況

◆組み換えタンパク質の主要企業プロフィール動向
・R&D SYSTEMS            
・THERMO FISHER SCIENTIFIC INC.     
・MERCK KGAA
・ABCAM PLC  
・ABNOVA CORPORATION       
・BIOLEGEND 
・BIO-RAD LABORATORIES, INC.           
・BPS BIOSCIENCE, INC.            
・ENZO LIFE SCIENCES, INC.    
・GENSCRIPT BIOTECH CORPORATION            
・MILTENYI BIOTEC    
・PEPROTECH, INC.     
・PROTEINTECH GROUP          
・SINO BIOLOGICAL INC.          
・ACROBIOSYSTEMS    
・AVIVA SYSTEMS BIOLOGY CORPORATION    
・CELLGENIX GMBH    
・ICOSAGEN AS
・NEUROMICS 
・PROSPEC-TECHNOGENE LTD.           
・PROTEOGENIX          
・RAYBIOTECH, INC.    
・RICHCORE LIFESCIENCES PVT LTD   
・STEMCELL TECHNOLOGIES INC.       
・STRESSMARQ BIOSCIENCES INC.       
・UNITED STATES BIOLOGICAL

(全172頁)



【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development, Academic Research), End User (Biotechnology Companies, CROs) - Global Forecast to 2026

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.2.1              INCLUSION & EXCLUSIONS
1.3             MARKET SCOPE
・       FIGURE 1............................... RECOMBINANT PROTEINS MARKET
1.3.1              YEARS CONSIDERED FOR THE STUDY
1.4             CURRENCY
1.5             LIMITATIONS
1.6             STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1             RESEARCH DATA
・       FIGURE 2.................................................. RESEARCH DESIGN.. 26
2.2             SECONDARY DATA
2.2.1              SECONDARY SOURCES.. 27
2.3             PRIMARY DATA
2.3.1              KEY DATA FROM PRIMARY SOURCES
・       FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.4             MARKET SIZE ESTIMATION
2.4.1              BOTTOM-UP APPROACH
・       FIGURE 4......... MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.4.2              TOP-DOWN APPROACH.. 30
・       FIGURE 5.......... MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.4.3              GROWTH FORECAST. 30
2.5             MARKET BREAKDOWN AND DATA TRIANGULATION
・       FIGURE 6.......................... DATA TRIANGULATION METHODOLOGY
2.6             ASSUMPTIONS FOR THE STUDY

3.... EXECUTIVE SUMMARY

・       FIGURE 7............ RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION)
・       FIGURE 8....... RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION)
・       FIGURE 9. RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2021–2026 (USD MILLION)
・       FIGURE 10......... RECOMBINANT PROTEINS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION)
・       FIGURE 11 GEOGRAPHIC SNAPSHOT OF THE GLOBAL RECOMBINANT PROTEINS MARKET

4.... PREMIUM INSIGHTS

4.1             RECOMBINANT PROTEINS MARKET OVERVIEW
・       FIGURE 12. INCREASING GOVERNMENT INVESTMENTS & THE RISING FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
4.2             ASIA PACIFIC: RECOMBINANT PROTEINS MARKET, BY APPLICATION & BY COUNTRY (2021)
・       FIGURE 13...... THE DRUG DISCOVERY & DEVELOPMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE, BY APPLICATION, FOR 2021
4.3             RECOMBINANT PROTEINS MARKET, BY END USER, 2021-2026
・       FIGURE 14. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES ARE EXPECTED TO BE THE LARGEST END USERS OF RECOMBINANT PROTEINS DURING THE FORECAST PERIOD
4.4             RECOMBINANT PROTEINS MARKET: GEOGRAPHIC SNAPSHOT
・       FIGURE 15.. CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・       FIGURE 16............... RECOMBINANT PROTEINS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.2.1              DRIVERS
5.2.1.1            RISING GOVERNMENT FUNDING AND INCREASING R&D EXPENDITURE IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
・       TABLE 1....... GOVERNMENT FUNDING FOR LIFE SCIENCE RESEARCH (2017-2020)
5.2.1.2            THE HIGH PREVALENCE OF INFECTIOUS & CHRONIC DISEASES
5.2.1.3            GROWING INDUSTRY-ACADEMIA COLLABORATIONS
5.2.1.4            PATENT EXPIRY OF BIOLOGICS
5.2.2              RESTRAINTS
5.2.2.1            THE DECLINING COST OF RECOMBINANT PROTEINS
5.2.3              OPPORTUNITIES
5.2.3.1            EMERGING ECONOMIES
5.2.3.2            RISING FOCUS ON PERSONALIZED MEDICINE AND PROTEIN THERAPEUTICS
・       TABLE 2........ COMMERCIALIZED RECOMBINANT PROTEINS USED IN MEDICINE
5.2.3.3            INCREASING FOCUS ON BIOMARKER DISCOVERY
5.2.4              COVID IMPACT ANALYSIS
5.3             PRICING ANALYSIS
・       TABLE 3....................... PRICE OF RECOMBINANT PROTEINS (USD)
5.4             STAKEHOLDER ANALYSIS.. 50
・       FIGURE 17........ RECOMBINANT PROTEINS MARKET- STAKEHOLDER ANALYSIS
5.5             VALUE CHAIN ANALYSIS.. 52
・       FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
5.6             RECOMBINANT PROTEINS FORMS AN INTEGRAL PART OF BIOTECHNOLOGY
・       FIGURE 19...................... BIOTECHNOLOGY ECOSYSTEM ANALYSIS
5.7             PORTER’S FIVE FORCES ANALYSIS
・       FIGURE 20......... REQUIREMENT OF HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
5.7.1              THREAT OF NEW ENTRANTS
5.7.2              THREAT OF SUBSTITUTES
5.7.3              BARGAINING POWER OF BUYERS
5.7.4              BARGAINING POWER OF SUPPLIERS
5.7.5              INTENSITY OF RIVALRY

6.... RECOMBINANT PROTEINS MARKET, BY PRODUCT

6.1             INTRODUCTION
・       TABLE 4.............. RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
6.2             GROWTH FACTORS AND CHEMOKINES
6.2.1              THIS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE RECOMBINANT PROTEINS MARKET IN 2020
・       TABLE 5. GROWTH FACTORS AND CHEMOKINES MARKET, BY REGION,
2019–2026 (USD MILLION)
6.3             IMMUNE RESPONSE PROTEINS
6.3.1              IMMUNE CHECKPOINT PROTEINS PLAY A MAJOR ROLE IN CANCER IMMUNOTHERAPY
・       TABLE 6.......... IMMUNE RESPONSE PROTEINS MARKET, BY REGION,
2019–2026 (USD MILLION)
6.4             STRUCTURAL PROTEINS
6.4.1              STRUCTURAL PROTEINS ARE UTILIZED IN CELL CULTURE APPLICATIONS AS ATTACHMENT FACTORS
・       TABLE 7.. STRUCTURAL PROTEINS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.5             MEMBRANE PROTEINS
6.5.1              MEMBRANE PROTEINS ARE RESPONSIBLE FOR REGULATING PROCESSES THAT HELP BIOLOGICAL CELLS SURVIVE. 61
・       TABLE 8.... MEMBRANE PROTEINS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.6             KINASE PROTEINS
6.6.1              KINASE PROTEINS PLAY A MAJOR ROLE IN SIGNAL TRANSDUCTION PATHWAYS
・       TABLE 9.. KINASE PROTEINS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.7             REGULATORY PROTEINS
6.7.1              REGULATORY PROTEINS HELP UNDERSTAND CELL CYCLE REGULATION AND CARCINOGENESIS
・       TABLE 10 REGULATORY PROTEINS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.8             RECOMBINANT METABOLIC ENZYMES
6.8.1              ENZYMES REGULATE PROTEIN INTERACTIONS
・       TABLE 11 RECOMBINANT METABOLIC ENZYMES MARKET, BY REGION,
2019–2026 (USD MILLION)
6.9             ADHESION MOLECULES AND RECEPTORS
6.9.1              CELL ADHESION MOLECULES FACILITATE EXTRACELLULAR MATRIX (ECM) INTERACTIONS
・       TABLE 12...... ADHESION MOLECULES AND RECEPTORS MARKET, BY REGION,
2019–2026 (USD MILLION)
6.10          OTHER RECOMBINANT PROTEINS
・       TABLE 13..... OTHER RECOMBINANT PROTEINS MARKET, BY REGION,
2019–2026 (USD MILLION)

7.... RECOMBINANT PROTEINS MARKET, BY APPLICATION

7.1             INTRODUCTION
・       TABLE 14....... RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
7.2             DRUG DISCOVERY & DEVELOPMENT
・       TABLE 15. RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019-2026 (USD MILLION)
・       TABLE 16. RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2019-2026 (USD MILLION)
7.2.1              BIOLOGICS
7.2.1.1            BIOLOGICS ARE USED TO TREAT CANCER, AUTOIMMUNE DISEASES, AND OTHER SERIOUS DISORDERS.. 67
・       TABLE 17................... RECOMBINANT PROTEIN BIOLOGICS DRUGS
・       TABLE 18..... RECOMBINANT PROTEINS MARKET FOR BIOLOGICS, BY REGION,
2019-2026 (USD MILLION)
7.2.2              VACCINES
7.2.2.1            RISING INCIDENCES OF INFECTIOUS DISEASES TO BOOST THE MARKET GROWTH FOR VACCINES.. 68
・       TABLE 19...... RECOMBINANT PROTEINS MARKET FOR VACCINES, BY REGION,
2019-2026 (USD MILLION)
7.2.3              CELL & GENE THERAPY
7.2.3.1            STEM CELL THERAPY AND CART THERAPIES HAVE INCREASED THE DEMAND FOR RECOMBINANT PROTEINS
・       TABLE 20........ RECOMBINANT PROTEINS MARKET FOR CELL & GENE THERAPY, BY REGION, 2019-2026 (USD MILLION). 70
7.3             ACADEMIC RESEARCH STUDIES
7.3.1              RECOMBINANT PROTEINS ARE USED IN MOLECULAR AND GENE EXPRESSION STUDIES, THUS AIDING MARKET GROWTH
・       TABLE 21.......... RECOMBINANT PROTEINS MARKET FOR ACADEMIC RESEARCH STUDIES,
BY REGION, 2019-2026 (USD MILLION)
7.4             BIOPHARMACEUTICAL PRODUCTION
7.4.1              RECOMBINANT PROTEINS ARE WIDELY USED FOR THE DEVELOPMENT OF PROTEIN-BASED DRUGS
・       TABLE 22......................... RECOMBINANT PROTEINS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2019-2026 (USD MILLION)
7.5             BIOTECHNOLOGY RESEARCH
7.5.1              THE INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS TO DRIVE MARKET GROWTH
・       TABLE 23.. RECOMBINANT PROTEINS MARKET FOR BIOTECHNOLOGY RESEARCH,
BY REGION, 2019-2026 (USD MILLION)
7.6             OTHER APPLICATIONS
・       TABLE 24............... RECOMBINANT PROTEINS MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)

8.... RECOMBINANT PROTEINS MARKET, BY END USER

8.1             INTRODUCTION
・       TABLE 25........... RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
8.2             PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
8.2.1              PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES ARE THE LARGEST END-USER SEGMENT FOR RECOMBINANT PROTEINS USED IN TARGET DETECTION & DRUG DISCOVERY
・       TABLE 26 RECOMBINANT PROTEINS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2019–2026 (USD MILLION)
8.3             BIOTECHNOLOGY COMPANIES
8.3.1              INCREASING NUMBER OF PROJECTS FOR PROTEIN-BASED RESEARCH DRIVES MARKET GROWTH
・       TABLE 27.. RECOMBINANT PROTEINS MARKET FOR BIOTECHNOLOGY COMPANIES,
BY REGION, 2019–2026 (USD MILLION)
8.4             ACADEMIC RESEARCH INSTITUTES
8.4.1              GROWING GOVERNMENT INVESTMENTS TO PROPEL MARKET GROWTH
・       TABLE 28.......... RECOMBINANT PROTEINS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION). 78
8.5             CONTRACT RESEARCH ORGANIZATIONS (CROS)
8.5.1              INCREASING OUTSOURCING OF SERVICES TO CROS DRIVES MARKET GROWTH
・       TABLE 29.......... RECOMBINANT PROTEINS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019–2026 (USD MILLION)
8.6             OTHER END USERS
・       TABLE 30 RECOMBINANT PROTEINS MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)

9.... RECOMBINANT PROTEIN MARKET, BY REGION

9.1             INTRODUCTION
・       TABLE 31..... RECOMBINANT PROTEINS MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2             NORTH AMERICA
・       FIGURE 21..... NORTH AMERICA: RECOMBINANT PROTEINS MARKET SNAPSHOT
・       TABLE 32... NORTH AMERICA: RECOMBINANT PROTEINS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 33... NORTH AMERICA: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 34... NORTH AMERICA: RECOMBINANT PROTEINS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 35.. NORTH AMERICA: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 36... NORTH AMERICA: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.2.1              US
9.2.1.1            THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET FOR RECOMBINANT PROTEINS DURING THE FORECAST PERIOD
・       TABLE 37 US NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020
(USD BILLION)
・       TABLE 38....... US: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 39.. US: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 40........... US: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 41...... US: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.2.2              CANADA
9.2.2.1            THE HIGH PREVALENCE OF CANCER AND FAVORABLE FUNDING SCENARIO IN CANADA IS EXPECTED TO SUPPORT MARKET GROWTH
・       TABLE 42 CANADA: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 43.............. CANADA: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 44.... CANADA: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 45........ CANADA: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3             EUROPE
・       TABLE 46 EUROPE: RECOMBINANT PROTEINS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 47 EUROPE: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 48.............. EUROPE: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 49.... EUROPE: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 50 EUROPE: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3.1              GERMANY
9.3.1.1            GERMANY HELD THE LARGEST SHARE OF THE MARKET IN EUROPE IN 2020
・       TABLE 51............ GERMANY: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 52............ GERMANY: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 53.. GERMANY: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 54...... GERMANY: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3.2              UK
9.3.2.1            GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH IN THE UK
・       TABLE 55....... UK: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 56.. UK: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 57........... UK: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY &DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 58...... UK: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3.3              FRANCE
9.3.3.1            INFRASTRUCTURAL DEVELOPMENT AND RISING LIFE SCIENCE R&D SUPPORTS MARKET GROWTH IN FRANCE
・       TABLE 59 FRANCE: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 60.............. FRANCE: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 61.... FRANCE: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 62 FRANCE: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3.4              ITALY
9.3.4.1            LIFE SCIENCE RESEARCH INVESTMENTS AND A FAVORABLE FUNDING SCENARIO ARE THE KEY GROWTH DRIVERS FOR MARKET GROWTH
・       TABLE 63.... ITALY: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 64 ITALY: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 65........ ITALY: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 66... ITALY: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3.5              SPAIN
9.3.5.1            A FAVORABLE SCENARIO FOR RESEARCH INITIATIVES DRIVES THE MARKET GROWTH IN SPAIN
・       TABLE 67.. SPAIN: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 68................. SPAIN: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 69....... SPAIN: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 70.. SPAIN: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3.6              REST OF EUROPE (ROE)
・       TABLE 71..... ROE: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 72 ROE: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 73.......... ROE: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 74..... ROE: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.4             ASIA PACIFIC
・       FIGURE 22.......... ASIA PACIFIC: RECOMBINANT PROTEINS MARKET SNAPSHOT
・       TABLE 75........ ASIA PACIFIC: RECOMBINANT PROTEINS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 76........ ASIA PACIFIC: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 77........ ASIA PACIFIC: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 78...... ASIA PACIFIC: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 79.. ASIA PACIFIC: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.4.1              JAPAN
9.4.1.1            ADVANCED HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH IN JAPAN
・       TABLE 80.. JAPAN: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 81................ JAPAN: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 82....... JAPAN: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 83.. JAPAN: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.4.2              CHINA
9.4.2.1            CHINA IS THE FASTEST-GROWING SEGMENT OF THE OVERALL APAC MARKET DURING THE FORECAST PERIOD
・       TABLE 84.. CHINA: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 85................ CHINA: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 86....... CHINA: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 87.. CHINA: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.4.3              INDIA

9.4.3.1            STRONG BIOPHARMACEUTICAL GROWTH AND THE RISING DEMAND FOR PHARMACEUTICALS ARE KEY MARKET DRIVERS FOR GROWTH IN INDIA
・       TABLE 88... INDIA: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 89................. INDIA: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 90........ INDIA: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 91... INDIA: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.4.4              REST OF ASIA PACIFIC (ROAPAC)
・       TABLE 92 ROAPAC: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 93.............. ROAPAC: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 94.... ROAPAC: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 95 ROAPAC: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.5             REST OF THE WORLD (ROW)
・       TABLE 96.... ROW: RECOMBINANT PROTEINS MARKET, BY PRODUCT,
2019–2026 (USD MILLION)
・       TABLE 97 ROW: RECOMBINANT PROTEINS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・       TABLE 98......... ROW: RECOMBINANT PROTEINS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATION, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 99.... ROW: RECOMBINANT PROTEINS MARKET, BY END USER,
2019–2026 (USD MILLION)

10.. COMPETITIVE LANDSCAPE

10.1          OVERVIEW
・       FIGURE 23......... KEY PLAYERS ADOPTED ORGANIC AND INORGANIC GROWTH STRATEGIES BETWEEN 2018 AND 2020
・       FIGURE 24............................. MARKET EVOLUTION FRAMEWORK
10.2          MARKET SHARE ANALYSIS, 2019
・       FIGURE 25...... RECOMBINANT PROTEINS MARKET, BY KEY PLAYERS, 2019
10.3          COMPETITIVE SCENARIO
10.3.1            PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2018–2020)
10.3.2            PRODUCT LAUNCHES & APPROVALS (2018-2020)
10.3.3            EXPANSIONS (2018-2020)
10.3.4            ACQUISITIONS (2018-2020)
10.4          COMPANY EVALUATION QUADRANT (2020)
10.4.1            VENDOR INCLUSION CRITERIA
10.4.2            STARS
10.4.3            EMERGING LEADERS.. 125
10.4.4            PERVASIVE PLAYERS.. 125
10.4.5            PARTICIPANTS
・       FIGURE 26.................. MNM VENDOR DIVE COMPARISON MATRIX: RECOMBINANT PROTEINS MARKET

11.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
11.1          R&D SYSTEMS
・       FIGURE 27 BIO‑TECHNE CORPORATION: COMPANY SNAPSHOT (2019)
11.2          THERMO FISHER SCIENTIFIC INC.
・       FIGURE 28. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
11.3          MERCK KGAA
・       FIGURE 29................. MERCK KGAA: COMPANY SNAPSHOT (2019)
・       TABLE 100 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD)
11.4          ABCAM PLC
・       FIGURE 30................... ABCAM PLC: COMPANY SNAPSHOT (2020)
11.5          ABNOVA CORPORATION
11.6          BIOLEGEND
11.7          BIO-RAD LABORATORIES, INC.
・       FIGURE 31..... BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
11.8          BPS BIOSCIENCE, INC.
11.9          ENZO LIFE SCIENCES, INC.
・       FIGURE 32....... ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2019)
11.10        GENSCRIPT BIOTECH CORPORATION
・       FIGURE 33............ GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2019)
11.11        MILTENYI BIOTEC
11.12        PEPROTECH, INC.
11.13        PROTEINTECH GROUP
11.14        SINO BIOLOGICAL INC.
11.15        ACROBIOSYSTEMS
11.16        AVIVA SYSTEMS BIOLOGY CORPORATION
11.17        CELLGENIX GMBH
11.18        ICOSAGEN AS
11.19        NEUROMICS
11.20        PROSPEC-TECHNOGENE LTD.
11.21        PROTEOGENIX
11.22        RAYBIOTECH, INC.
11.23        RICHCORE LIFESCIENCES PVT LTD
11.24        STEMCELL TECHNOLOGIES INC.
11.25        STRESSMARQ BIOSCIENCES INC.
11.26        UNITED STATES BIOLOGICAL
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
12.. APPENDIX



掲載企業リスト

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。